AptaBio Therapeutics Inc (293780) — Net Asset Quality Index
AptaBio Therapeutics Inc (293780) has a Net Asset Quality Index of 66.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩67.12 Billion minus total liabilities of ₩22.51 Billion yields net assets of ₩44.61 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 293780 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
AptaBio Therapeutics Inc Net Asset Quality Index Over Time (2017–2024)
This chart shows how AptaBio Therapeutics Inc's Net Asset Quality Index has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the index stands at 66.5%, representing net assets of ₩44.61 Billion against total assets of ₩67.12 Billion KRW. See 293780 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for AptaBio Therapeutics Inc (2017–2024)
The table below presents the year-by-year Net Asset Quality Index for AptaBio Therapeutics Inc from 2017 to 2024, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see AptaBio Therapeutics Inc (293780) market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 70.0% | ₩54.20 Billion | ₩77.43 Billion | ₩23.24 Billion | ▲ +3.7 pp |
| 2023 | 66.3% | ₩61.36 Billion | ₩92.52 Billion | ₩31.16 Billion | ▼ -27.0 pp |
| 2022 | 93.3% | ₩52.37 Billion | ₩56.11 Billion | ₩3.74 Billion | ▼ -1.7 pp |
| 2021 | 95.0% | ₩61.67 Billion | ₩64.91 Billion | ₩3.25 Billion | ▼ -0.5 pp |
| 2020 | 95.5% | ₩72.04 Billion | ₩75.44 Billion | ₩3.40 Billion | ▼ -1.6 pp |
| 2019 | 97.1% | ₩75.16 Billion | ₩77.40 Billion | ₩2.25 Billion | ▲ +7.0 pp |
| 2018 | 90.1% | ₩18.31 Billion | ₩20.33 Billion | ₩2.02 Billion | ▲ +376.7 pp |
| 2017 | -286.7% | ₩-31.54 Billion | ₩11.00 Billion | ₩42.54 Billion | — |